Hong Kong-listed Kindstar Global (Kindstar Globalgene Technology, Inc.) disclosed that it bought back 34,000 ordinary shares on 4 September 2026 via on-market transactions. The shares were repurchased at prices ranging from HKD 0.955 to HKD 0.985, for a total consideration of HKD 0.03 million, implying a volume-weighted average cost of HKD 0.9568 per share.

Following the transaction, the company’s treasury share balance increased to 8.86 million, while the number of issued shares excluding treasury stock edged down 0.00329 % to 1.03 billion. Total issued share capital remained unchanged at 1.04 billion shares, as the repurchased stock has been retained in treasury and not cancelled.

The buyback forms part of the repurchase mandate approved on 5 June 2026, which authorises Kindstar Global to reacquire up to 103.43 million shares. Cumulative repurchases under this mandate now stand at 1.80 million shares, equivalent to 0.17 % of the company’s issued share base at the mandate date.

In line with Hong Kong Stock Exchange regulations, Kindstar Global is subject to a moratorium on issuing new shares or disposing of treasury shares until 4 October 2026.